Search

Displaying results 4641 - 4650 of 10000 in total
  1. Drug

    Piroximone

    go.drugbank.com/drugs/DB19750
    Experimental

    Piroximone has a monoisotopic molecular weight of 217.09 Da.

    Categories: Compounds used in a research, industrial, or household setting
  2. Drug

    Mecrylate

    go.drugbank.com/drugs/DB21343
    Experimental

    Mecrylate has a monoisotopic molecular weight of 111.03 Da.

    Categories: Compounds used in a research, industrial, or household setting
  3. Drug

    Furafylline

    go.drugbank.com/drugs/DB14029
    Experimental

    It was developed on the context of asthma as a long-acting alternative for [theophylline].

  4. Drug

    Ordopidine

    go.drugbank.com/drugs/DB05196
    Investigational

    ACR325 is a dopaminergic stabiliser, which has demonstrated promising results in disease models for motor functions and psychoses.

  5. Drug

    Nitecapone

    go.drugbank.com/drugs/DB20402
    Experimental

    Nitecapone has a monoisotopic molecular weight of 265.06 Da.

    Categories: Compounds used in a research, industrial, or household setting
  6. Drug

    Setoperone

    go.drugbank.com/drugs/DB20520
    Experimental

    Setoperone has a monoisotopic molecular weight of 401.16 Da. … The usage of the INN stem '-perone' in the name indicates that Setoperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.

    Categories: Compounds used in a research, industrial, or household setting
  7. Drug

    MB07811

    go.drugbank.com/drugs/DB05192
    Investigational

    MB07811, a small molecule that is administered orally, has been extensively studied preclinically and is currently undergoing clinical testing.

  8. Drug

    NUC B1000

    go.drugbank.com/drugs/DB05242
    Experimental

    On January 11, 2008, it was announced that NUC B1000 was entering a phase 1 human safety study of its experimental treatment for chronic Hepatitis B virus (HBV) infection. … NUC B1000 is an expressed interfering RNA (eiRNA)- based product consisting of a plasmid DNA construct designed to produce four short interfering RNA (siRNA) molecules, formulated with a proprietary cationic-lipid

  9. Drug

    SR-123781A

    go.drugbank.com/drugs/DB05361
    Investigational

    SR-123781A is a synthetic hexadecasaccharide Factor IIa and Xa antagonist. It is under investigation by Sanofi-Aventis and Organon for the treatment of thrombosis and acute coronary syndromes (ACS).

  10. Drug

    AT-301

    go.drugbank.com/drugs/DB16507
    Investigational

    AT-301 was under investigation in clinical trial NCT01675284 to evaluate the safety, reactogenicity, and humoral immune responses to an inactivated H5N1 influenza vaccine